<DOC>
	<DOCNO>NCT02993874</DOCNO>
	<brief_summary>The aim study verify effect creatine supplementation associate clinical treatment functional capacity patient intermittent claudication .</brief_summary>
	<brief_title>Creatine Supplementation Patients With Intermittent Claudication .</brief_title>
	<detailed_description>The aim study verify effect creatine supplementation associate clinical treatment functional capacity patient intermittent claudication . The sample compose patient intermittent claudication sex . The patient ramdomized double-blind procedure receive seven day ( load ) posteriorly 49 day ( maintenance ) creatine ( Cr ) supplementation placebo ( PLA ) , associated clinical treatment . Before ( `` baseline '' ) , `` loading '' period maintenance period supplementation , patient go functional capacity evaluation . The fuctional capacity evaluation evaluate six minute-walking test . For statistical analysis use ANOVA two factor repeat measurement , ( Cr PLA ) group time ( pre , post-loading post-maintenance ) , need post-hoc Newman keuls . The adopted level significance P &lt; 0.05 .</detailed_description>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>symptom pain sixminute walk test limit leg pain due intermittent claudication . present peripheral artery disease ( Anklearm index &lt; 0.90 ) one limb . Asymptomatic intermittent claudication determine clinical history . Not muscle joint injury make impossible practice physical activity . attend 15 % intervention session visit laboratory . Stick physical activity program addition offer study . use medication regularly . aggravation disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ergonemic resource</keyword>
	<keyword>Walking capacity</keyword>
	<keyword>Peripheral artery disease</keyword>
</DOC>